Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CpG island methylator phenotype is an independent predictor of survival after curative resection for colorectal cancer: A prospective cohort study.

Journal of gastroenterology and hepatology - 1 Aug 2017

Kim Chang Hyun, Huh Jung Wook, Kim Hyeong Rok, Kim Young Jin

Abstract excerpt

BACKGROUND AND AIMS: The CpG island methylator phenotype (CIMP) is found in approximately 30% of colorectal cancer (CRC) cases. However, the role of CIMP status in predicting oncologic outcomes in curatively resected CRC is still unclear. STUDY: Between January 2006 and December 2006, we retrospectively reviewed 157 consecutive patients who underwent curative surgery for CRC. Prognostic significance of CIMP...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cohort Studies
Share to Colectomy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Colorectal Neoplasms

Share to CpG Islands

Share to DNA Methylation

Share to Forecasting

Share to Neoplasm Staging

Share to Survival Rate

Source

Identifiers

PMID: 28087988
DOI: 10.1111/jgh.13734

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CpG island methylator phenotype is an independent predictor of survival after curative resection for colorectal cancer: A prospective cohort study.PMID 28087988Read ↗

No association of CpG island methylator phenotype and colorectal cancer survival: population-based study.Semantic proximity Read ↗

The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy.Semantic proximity Read ↗

The role of the CpG island methylator phenotype on survival outcome in colon cancer.Semantic proximity Read ↗

Prognostic value of CpG island methylator phenotype among hepatocellular carcinoma patients: A systematic review and meta-analysis.Semantic proximity Read ↗

Epigenetic alterations in colorectal cancer: the CpG island methylator phenotype.Semantic proximity Read ↗

Meta-Analysis of the Prognostic and Predictive Role of the CpG Island Methylator Phenotype in Colorectal Cancer.Semantic proximity Read ↗

Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis.Semantic proximity Read ↗

CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer.Semantic proximity Read ↗

Prognostic Value of Methylator Phenotype in Stage III Colon Cancer Treated with Oxaliplatin-based Adjuvant Chemotherapy.Semantic proximity Read ↗

Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location.Semantic proximity Read ↗

Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review.Semantic proximity Read ↗

Methylator phenotype in colorectal cancer: A prognostic factor or not?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.